AI Assistant
Blog
Pricing
Log In
Sign Up
PRIMARY EWING'S SARCOMA: 75% DISEASE-FREE 5 YEAR SURVIVAL WITH T-2 CHEMOTHERAPY – CONSIDERATIONS FOR FUTURE THERAPEUTIC TRIALS
Details
Cite
Export
Add to List
The content you want is available to Zendy users.
Already have an account? Click
here.
to sign in.
